However, while some groups are falling ‘short’ on volunteers, others are not accepted into phase III trials. Oxford-AstraZeneca, which is one of the most promising candidate vaccines, is running phase III trials in India as ‘Covishield’. While the tests are receiving an active response from the public, recent reports have suggested that at least seven participants are ineligible for vaccine trials, as the Serum Institute of India began phase III testing at a government facility in Pune.
According to an agency report, the volunteers in question were disqualified for medical reasons and would be screened again this week.
“The seven candidates who were selected on Monday have become ineligible due to various medical reasons, including the antibody test that came back positive for some … Some more candidates have been screened today (Tuesday) and if their test results for antibodies and COVID-19 are negative and if they are eligible for other medical reasons they will be given the candidate vaccine …
It should be noted that while volunteers, in any trial, have the option of opting out or dropping out of the trial at any time, there are specific guidelines as to who can sign up for the trial, take the trial and follow it globally.
.
